+53.3%
THC vs AVAV
-43.9%
+97.2%
-18.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | AVAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.0% | -9.8% | +7.9% | -2.8% |
| 7D | +5.9% | -24.3% | +30.2% | +3.7% |
| 30D | +10.8% | -28.9% | +39.7% | +8.2% |
| 3M | +9.4% | -39.3% | +48.7% | +6.3% |
| 6M | +53.3% | -38.8% | +92.0% | +48.9% |
| All | +53.3% | -43.9% | +97.2% | +48.9% |
Cumulative growth
Daily Returns
Daily percentage return beside AVAV.
Daily Out/Under-Performance
Portfolio return minus AVAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling